COVID-19 Pandemic Leads to Millions of Missed Cancer Screenings
The COVID-19 pandemic has resulted in millions of missed cancer screenings worldwide, raising concerns about delayed diagnoses and highlighting the need for catch-up screening initiatives to mitigate long-term consequences on cancer detection and treatment.
January 2023
Rising Incidence of Esophageal Cancer and Barrett’s Esophagus Signals Urgent Need for Early Detection Strategies
The increasing incidence of esophageal cancer and Barrett’s esophagus underscores the urgent need for early endoscopic examination and surveillance programs to improve outcomes for individuals at risk of these conditions.
January 2023
Promotion of Prostate Cancer Testing in Asymptomatic Men Questioned
The benefit of promoting prostate cancer testing in asymptomatic men is uncertain, with limited evidence of significant benefits outweighing clear harms, prompting reevaluation of screening recommendations in this population.
January 2023
Overdiagnosis of Melanocytic Skin Lesions Raises Concerns
Many pathologists acknowledge the phenomenon of overdiagnosis in skin cancer, highlighting the need for standardized diagnostic criteria and continued education to minimize unnecessary treatments and psychological distress in patients.
December 2022
Open-Angle Glaucoma in Adults with Seropositive Rheumatoid Arthritis: Exploring Associations
A potential link between seropositive rheumatoid arthritis (RA) and primary open-angle glaucoma (POAG) is identified, highlighting the importance of comprehensive ophthalmologic evaluation and disease management in RA patients to prevent visual impairment.
December 2022
Single Dose of Human Papillomavirus Vaccine Demonstrates Protective Efficacy
A single dose of the human papillomavirus (HPV) vaccine shows protective efficacy against cervical cancer, offering a simplified vaccination schedule and facilitating immunization efforts to reduce HPV-related morbidity and mortality.
December 2022
New Prostate Cancer Risk Algorithm: Insights from Epidemiological Studies
An updated risk algorithm for prostate cancer identifies age as the predominant risk factor, with almost all cases occurring after age 55 years, highlighting the importance of age-stratified screening and early detection efforts in reducing prostate cancer mortality.
November 2022
Skin Cancer Incidence Trends in the United States: A Concerning Rise
Skin cancer incidence in the United States has steadily increased between 1973 and 2015, highlighting the need for enhanced prevention efforts and public health initiatives to address this concerning trend and reduce the burden of skin cancer.
October 2022
